Mucopolysaccharidoses (MPS) Latest Advances
Find the Latest Research About Mucopolysaccharidoses (MPS)
Last Updated: 11/08/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 3852 publications
Rebisufligene etisparvovec: The first AAV9-mediated SGSH gene therapy approved for the treatment of mucopolysaccharidosis type IIIA (MPS IIIA).
Journal: Drug discoveries & therapeutics
Published: October 28, 2026
Mucopolysaccharidosis type IIIC diagnosed at the age of 12 years: Why was the disease diagnosed so late?
Journal: Pediatric endocrinology, diabetes, and metabolism
Published: October 22, 2026
Outcomes of adult patients with mucopolysaccharidoses type Ⅰ treated by enzyme replacement therapy
Journal: Beijing da xue xue bao. Yi xue ban = Journal of Peking University. Health sciences
Published: October 15, 2026
Multimodal ophthalmic findings in patients with mucopolysaccharidosis: A prospective observational study.
Journal: European journal of ophthalmology
Published: October 09, 2026
Expeditious synthesis of fluorogenic enzyme substrates for mucopolysaccharidosis types I and II.
Journal: Organic & biomolecular chemistry
Published: October 07, 2026
Metabolomic profiling in treated mucopolysaccharidosis IH reveals candidate biomarkers and adjunctive therapeutic pathways.
Journal: medRxiv : the preprint server for health sciences
Published: October 01, 2026
Correction: McDaniel et al. Personalized Drug Repurposing Screen Identifies Patient-Specific Therapeutic Candidates for Mucopolysaccharidosis Type IIIB. J. Pers. Med. 2026, 16, 369.
Journal: Journal of personalized medicine
Published: September 29, 2026
Generation of induced pluripotent stem cell lines TRNDi045-A-40 and TRNDi045-A-41 modeling mucopolysaccharidosis type IIIA and type I from parental KOLF2.1J.
Journal: Stem cell research
Published: September 29, 2026
Mass spectrometry measurements of glycosaminoglycans to assess disease-modifying treatments for the mucopolysaccharidoses: Methodological considerations.
Journal: Molecular genetics and metabolism
Published: September 20, 2026
Early Recognition of Patients with Neuronopathic Forms of Mucopolysaccharidosis Type II in Clinical Practice.
Journal: Medical sciences (Basel, Switzerland)
Published: August 28, 2026
Last Updated: 11/08/2026